And as a ex-patient (to my grace) and owner of OCC (to my frustration) of a decade I can tell you OCC was in a constant CR/announcement ebb and flow for years. THen they got the BioHorizons deal. That's the difference. In some respects OSX is ahead of OCC in its revenue growth rates (until the latest quarter for OCC) and many multiple sales locations.
That OCC is not trading higher having a manufacturing and marketing deal with a top 5 dental pharma is a joke. But for OSX all it needs is one decent partnership or contract like OCC. The BioHorizons deal will see OCC go cash positive and get its scaffold up in nerve (already approved in Oz) and tendon. Then onto ATI. I suspect OSX has similar potential, when it sorts its cash situation.
Cash management at OSX has been woeful. Awful. But its also very cheap here for its prospects. I just bought more today and will buy more on any drops. Its a risky call option in effect, but showing value. OSX, like OCC, has excellent products. They just have not been fully appreciated by either surgical markets, or investment markets yet. Stating obvious stuff of course.
A decent creditor will see the value and provide capital. It often explains the apparent indolence of management, that they are negotiating. Sometimes of course it does not!
- Forums
- ASX - By Stock
- OSX
- Ann: Investor Presentation
Ann: Investor Presentation, page-25
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSX (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $4.853M |
Open | High | Low | Value | Volume |
4.2¢ | 4.2¢ | 4.1¢ | $28.26K | 677.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1970764 | 4.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 101043 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1970764 | 0.041 |
4 | 435000 | 0.040 |
1 | 25641 | 0.039 |
2 | 578945 | 0.038 |
1 | 138000 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 101043 | 1 |
0.043 | 159803 | 2 |
0.044 | 176953 | 2 |
0.047 | 180000 | 1 |
0.048 | 15000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online